Menarini bags blood cancer drug with $677M Stemline acquisitionItalian drugmaker Menarini has agreed to buy Stemline Therapeutics, bolting on an already-approved drug for a rare form Share XMenarini bags blood cancer drug with $677M Stemline acquisitionhttps://pharmaphorum.com/news/menarini-bags-blood-cancer-drug-with-677m-stemline-acquisition/
